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The annual meeting of the European Association of Echocardiography (EuroEcho-Imaging) was held in Vienna, Austria. In the present paper, we
present a summary of the ‘Highlights’ session.
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Introduction
The third annual scientific meeting of the European Association of
Cardiovascular Imaging (EACVI), EuroEcho-Imaging 2014, was held
in Vienna, Austria. The main themes were 3-dimensional imaging
and imaging in acute cardiac care. The meeting was a great success
with a record number of participants (.3500 delegates) and over
1300 abstracts submitted. The last day of the meeting, the ‘Highlights’
session wrapped up the event with a summary of the most relevant
abstracts presented throughout the congress. A short report of
this session is presented below.
Heart failure
Patients with non-ischaemic cardiomyopathy are better responders
to cardiac resynchronization therapy (CRT) than those with ischae-
mic cardiomyopathy. It was therefore relevant to identify echocar-
diographic predictors of ischaemic and non-ischaemic left bundle
branch block (LBBB). Using 2-dimensional speckle tracking echocar-
diography (2D-STE) analysis, Baum et al. have investigated displace-
ment, transversal, and longitudinal strains. Only longitudinal strain
was accurate to distinguish ischaemic from non-ischaemic LBBB.1
The comparison of peak basal longitudinal systolic strain between
septal and posterolateral wall helped to distinguish LBBB with or
without coronary artery disease.
Mechanical dyssynchrony may be assessed visually. Szulik et al.
have underlined the value of visual assessment of left ventricular
(LV) apical rocking. Nevertheless, visual assessment is difficult to
standardize,2 and in this regard, they identified two new quantitative
tools based on 2D-STE techniques: (i) the early systolic peak long-
itudinal strain/global longitudinal strain ratio, and (ii) the positive/
negative ratio of peak left regional displacement at end-systole (a para-
metric imaging is generated and displayed in Figure 1). These two
approaches measure the amount of septal flash and LV apical rocking.
Regarding the prediction of LV reverse remodelling at 6-month post
CRT, these two parameters showed similar accuracy (area under the
curve 0.85) and reproducibility (intra-class correlation coefficient
for intra- and inter-observer variability  0.9)3 (Figure 1).
Hasselberget al.4 haveassessedat the mechanical consequencesof
CRT and their relationships with LV reverse remodelling. They found
that remodelling process was more related to improvement of LV
longitudinal than circumferential function.
Cardiotoxicity is a leading cause of morbidity and mortality in
cancer survivors. Early detection could improve the management
and prognosis in these patients. Blazquez Bermejo et al.5 performed
echocardiography before and regularly after a treatment by chemo-
therapy (alkylating agents and anthracyclines 90%, radiotherapy 
1/3 of the wall population). They demonstrated a decrease in LV
global longitudinal strain (GLS) 15% at 3-month follow-up echocar-
diography in patients who developed cardiotoxicity (i.e. defined as
Cardiotoxicity diagnosis: LVEF decrease .10% and below 55% at 12
months; 11% of patients studied). By opposition, there was no
change in LV longitudinal function in patients without cardiotoxicity.
These results support the systematic use of GLS in these patients.
In a large cohort of hypertrophic cardiomyopathy (n ¼ 472)
explored with a median follow-up of 4.4 years, Reant et al.6 have
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demonstrated that a previous history of non-sustained ventricular
tachycardia, NYHA functional class III-IV, LV end-systolic volume,
GLS ≤ 14%, and resting LV outflow tract gradient ≥30 mmHg
were independent predictors of cardiovascular death or appropriate
implantable cardioverter defebrillator therapy.
Recent data in cardiac amyloidosis (CA) have encouraged the use
of LV longitudinal strain. Ternacle et al.7 have reported the lack of dif-
ference in late gadolinium enhancement (LGE) according to CA aeti-
ologies. However, they found an inverse relationship between the
degree of alteration of LV longitudinal strain and the amount of fibro-
sis, as estimated by LGE. An apical longitudinal strain greater than
214.5% was an independent prognostic marker, regardless CA
aetiologies.
Valvular heart disease
The major role of multi-imaging modalities in the assessment, man-
agement, and risk stratification of patients with valvular heart
disease continues to grow up. This year again, the large majority of
selected abstracts in the field of valvular heart disease explored
aortic stenosis (AS). In this regard, Saura et al.8 measured using real-
time 3D transoesophageal (TOE) echocardiography the planimetry
of aortic valve area in 282 AS patients. They reported that this param-
eter was independently associated with significant reduced survival
and that 0.8 cm2 (and not 1 cm2) was the most appropriate cut-off
to predict mortality.
Following transcatheter aortic valve implantation, Scherzer et al.9
reported the serial pre- and post-intervention (i.e. at 30-day,
6-month, and 1-year follow-up) Nt-pro BNP level of 142 patients.
They found a progressive and significant decrease in the biomarker
level and that both baseline (i.e. pre-intervention) and serial
changes in Nt-pro BNP [Hazard ratio (HR) ¼ 1.34, P ¼ 0.012 and
HR ¼ 1.58, P ¼ 0.0002, respectively] were associated with reduced
mid-term survival.
Kramer et al.10 have elegantly studied 77 patients with serial echo-
cardiographies showingevolution fromnon-severeAS todiagnosisof
severe AS (aortic valve area ,1 cm2). Subsequently, the patients
were studied according to mean transvalvular pressure gradient
(i.e. ≥ or,40 mmHg), and patients with low gradient were subcate-
gorized according to indexed stroke volume (i.e. ≥ or,35 mL/m2).
Patientswithhighgradient (n ¼ 31)depicted fasterprogressionofAS
from baseline to follow-up, with significant greater decrease in aortic
valve area (P ¼ 0.044) and increase in peak aortic velocity (P,
0.001), compared with patients low flow-low gradient AS (n ¼ 28).
In contrast, patients with low flow-low gradient showed the worst
LV myocardial longitudinal impairment and, as a result, significantly
worst functional deterioration and lower mid-term survival (P ¼
0.021).
In two separately analysed studies including symptomatic patients
with severe AS and preserved LV ejection fraction, Galli et al.11,12
aimed to investigate the prognosis significance of both reduced RV
function, as assessed using TAPSE, and reduced LA longitudinal func-
tion (Figure 2). In a cohort of 201 patients, they have first demon-
strated a significant impact of reduced TAPSE (i.e. ≤17 mm) on
overall mortality (P ¼ 0.03). Similarly, they secondly (n ¼ 178) iden-
tified that peak LA strain ≤23% was significantly associated with
increased risk of 2-year occurrence of major adverse cardiovascular
event (P ¼ 0.03) and with trend to higher mortality (P ¼ 0.05).
In a tremendous study including patients with heart failure and
reduced LV ejection fraction, Bandera et al.13 simultaneously per-
formed stress exercise echocardiography combined with cardiopul-
monary exercise test including gas exchange analysis. They classified
Figure1 New quantitative approach based on longitudinal assessment of strain: detection of both negative and positive strain peaks in first half of
systole. Start systolic index (%) ¼ integrates peak strain values and global strain values; Color map: Red (contraction); Blue (stretching).
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their patients according to resting and exercise MR severity [Group
A: both resting and exercise effective regurgitant orifice area (EROA)
,20 mm2, n ¼ 60; Group B: resting EROA, 20 mm2 but exercise
EROA. 20 mm2, n ¼ 17; Group C: both resting and exercise
EROA. 20 mm2, n ¼ 25). They found that patients in the Group
B (i.e. those with dynamic MR) had functional limitation similar to
patients with resting severe MR, mainly characterized by develop-
ment of exercise pulmonary hypertension. In addition, patients
with resting severe MR depicted the worst profile in term of
bi-ventricular remodelling, lack of contractile reserve, and impaired
ventilatory function, and those without exercise severe MR had the
best functional status and outcome. Furthermore, patients in
Group B seem have intermediate outcome compared with the two
other groups.
Finally, the functional and prognosis significance of left-sided valvu-
lar thickening (LVT) was tested in 150 patients with systemic light-
chain amyloidosis by Pradel et al.14 They have found that patients
with LVT (42%), as visually assessed using echocardiography, more
frequently have Mayo clinic stage III and NYHA functional class ≥III
than those without LVT. Consistently, they reported a significant
lower overall survival at 2- and 6-year follow-up.
3-Dimensionnal echocardiography
3D echocardiography is a fascinating and emerging technology for
imaging the heart. Real-time full-volume 3D echocardiography
(3DE) allows rapid and non-invasive measurement of left (LA) and
right atrial (RA) volume without making geometric assumptions.
Different softwares with semiautomatic endocardial contour finding
algorithms fromdifferent commercial providersareavailable.Mueller
et al.15 have compared LA and RA volume determined by these
algorithms. They found an excellent linear correlation and agreement
for both LA and RA between volumes determined by EchoPAC and
QLAB software, respectively, indicating that values of LA and RA
atrial volume obtained by either algorithm can be compared, for
example during follow-up examinations.
Luo et al.16 have studied 82 consecutive bradycardia patients re-
quiring right ventricular (RV) pacing with dual-chamber devices.
They have performed 3DE before and 12 months after RV pacing
to determine the effect on LV volumes, mass, and LV global deform-
ation. Theyobserved an increase in LV volumes and mass, a reduction
in LV ejection fraction and a significant reduction in global strain (lon-
gitudinal, radial, and circumferential).
In a study fromDreyfuset al.,17 TOE3Ddynamic volumetric dataof
the tricuspid annulus (TA) were acquired in 184 patients. Long- and
short-axis diameters and the area of the TA at the time of its maximal
opening were measured. The eccentricity index (EI) of the TA was
defined as long-axis/short-axis ratio and TA orientation as the
angle between the interatrial septum axis (aortic valve on the top
at 08) and the long-axis in the surgical view. 3D-TOE allowed a
good assessment of the TA shape and orientation, which is signifi-
cantly different among individuals. TA dilatation occurred homoge-
neously in all the directions of the RV free wall as attested by the
very good correlation between the TA area and both long axis (r ¼
0.89, P, 0.0001) and short axis (r ¼ 0.88, P, 0.0001). TA dilata-
tion, as shown by increase in TA area, was associated with a small de-
crease of EI, thus a trend to a more circular TA. All orientations of TA
were observed, from 58 to 1758 (mean ¼ 878 + 2578) with a
bimodal distribution (most frequently at 408 and 1508).
Sotaquira et al.18 have developed a semi-automated method for
3D area of regurgitant orifice (ARO) quantification from TOE
images (Figure 3) and validated it against manual planimetry in 25
patientswith mild to severe mitral regurgitation (MR). On the systolic
frame, an initial supervised segmentation of the region including the
ARO was performed, followed by an automated graph-based extrac-
tion of ARO 3D contour, from which 3D surface and 2D projected
areas, circularity (CI) and planarity (PI) indices were computed.
The proposed semi-automated method resulted in accurate detec-
tion of ARO compared with manual planimetry. 3D ARO assessment
showed underestimation of 2D measures, together with generally
non-circular and non-planar orifices, highlighting the limitations of
current clinical approach in the assessment of MR severity.
Miglioranza et al.19 compared the role of 2DE diameters and 3DE
TA surface area (TASA) to predict the severity of functional tricuspid
regurgitation (FTR) in a prospective cross-sectional study of 24
patients. In comparison with 2DE TA diameters, TASA showed
better correlations (P, 0.0001) with 3D parameters of FTR severity.
Considering the FTR severity as the outcome, receiver operative
characteristic (ROC) curve analysis revealed that TASA has a greater
predictive power to discriminate severe from non-severe FTR [area
undercurve (AUC)¼ 0.84] than2DETAdiameters measured in four-
chamber (AUC¼ 0.63) or parasternal long-axis view (AUC¼ 0.51).
A study from Meyer et al.20 sought to evaluate regional LV function
after transfemoral (TF) and transapical (TA)-TAVI by 3D-STE com-
pared with Cardiac Magnetic Resonance feature tracking (CMR -
FT) analysis performed 3 months after TAVI in 36 consecutive
Figure 2 Measurement of LA strain in patients with aortic
stenosis.
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patients (18 TA- and 18 TF-TAVI) without atrial fibrillation or prior
myocardial infarction. While CMR strain analysis detects apical LV
dysfunction afterTA-TAVI, 3D-STE was less sensitive in the detection
of the apical function defect.
Real-time 3DcontrastTOEhaspotential advantage for thediagno-
sis of small patent foramen ovale (PFO). It also allows direct visualiza-
tion of the entire fossa ovalis and surrounding structures. It results in
more accurate diagnosis of PFO by directly visualizing the bubbles
crossing the fossa ovalis. Rotzak et al.21 performed RT3D contrast
TOE in 121 consecutive patients referred for stroke. The diagnosis
of PFO was obtained in 25 patients. In three of them, the bubbles
were visualized only on RT3D. High-quality 3D images suggested
that 3DTEE is feasible and provided detailed description of the
atrial septum anatomy and PFO anatomy.
Goebel et al.22 assessed LA appendage (LAA) dimensions com-
paring 2D- with 3D-TOE measurements before, during, and 45 days
after intervention in 74 patients undergoing percutaneous LAA occlu-
sion by the Watchmanw device. Compared with 3D-TOE, 2D-TOE
significantly underestimates maximal LAA orifice diameter and is asso-
ciated with higher observer variability and lower reliability. Finally,
comparing the EI, device implantation leads to a change of LAA orifice
shape and dimensions.
CMR Imaging
CMR images contain an abundance of quantifiable information. Ana-
lysis approaches are mostly manual and thus time consuming. CMR
LGE images have been shown to be accurately quantified using a
fully automated 3D LV myocardial scar detection using a Gaussian
mixture model compared with the manual gold standard (Figure 4).23
An elegant experimental model used CMR to study cardiotoxic
effects. Authors demonstrated that the encapsulation of doxorubicin
Figure3 Newcalculation of the anatomic regurgitantorifice in mitral valve regurgitation from3D ultrasound dataset allowing tocompare3D area
and 2D projected area.
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with liposome resulted in less adverse cardiac remodelling (LV ejec-
tion fraction, RV ejection fraction, and prevalence of myocardial
fibrosis) compared with standard doxorubicin.24
Incidental non-cardiac findings are not rare. In 5135 CMR studies
from three centres, the overall prevalence was 6.1%. Severe findings
were found in 1.6% of CMR studies. The severe findings were more
common in men and in those undergoing stress CMR, possibly
related to higher prevalence of shared risk factors (e.g. smoking)
for other pathologies.25
In patients with severe primary MR with hearts of normal size and
function, 29% showed LV remodelling and LV impairment 6 months
after mitral valve surgery. LGE was associated with post-operative
impairment (80% with post-op LVEF, 50% showed LGE compared
with 23% if LVEF . 50%, P ¼ 0.047).26
Suspected inflammatory pericarditis benefits from a comprehen-
sive CMR approach assessing pericardial and cardiac morphology in-
cluding tissue characterization. In addition, a positive relationship
between the degree of pericardial thickening and other parameters
of inflammation was observed.27
In a randomized trial comparing the value of cardiac CT and CMR
approaches to assess the LA and pulmonary veins prior to radio-
frequency ablation in patients with drug refractory paroxysmal or
persistent atrial fibrillation (AF) LA volume measured by CMR
remained the only robust independent predictor of AF recurrence.
A lower overall cumulative radiation was observed despite similar
outcomes for CMR-guided compared with CT-guided AF ablations
(32.8+ 23.5 vs. 40.4+ 23.7 mSv, P, 0.005).28
The LA volumes determined by CMR can predict AF and adverse
events in hypertrophic cardiomyopathy,whereas prevalence of myo-
cardial fibrosis cannot. This interesting finding was presented based
on retrospective data from 352 patients across five centres with a
mean follow-up of 41+24 months.29
The differentiation of physiological from pathological LV hyper-
trophy can be challenging. A CMR study with male professional ath-
letes (n ¼ 75), male hypertrophic cardiomyopathy (n ¼ 92), and
male sedentary healthy volunteers showed that despite similar LV
mass indexes for athletes and hypertrophic cardiomyopathy patients,
a number of geometric indices combining regional hypertrophy and
Figure4 Top panel, first row shows short-axis LGE images with manual contouring of the area of myocardial infarction as the gold standard (GS).
Top panel, second row displays the area of infarction identified using the Gaussian mixture model (GMM). Bottom panel shows in a Bland–Altman
graph the minimal systemic bias and the excellent 95% agreement between the two methods.
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LV size allowed reliable distinction between the two forms of LV
hypertrophy.30
A CMR study (n ¼ 94, median 61-month follow-up) was pre-
sented and aimed to identify whether delayed revascularization in
patients with ischaemic heart failure and evidence of viability was
associated with improved survival compared with medical therapy
alone. Patients with significant viability and ischaemic heart failure
with NYHA III-IV derived most benefit from delayed revasculariza-
tion. Patients with no viability, or with evidence of viability and
NYHA I-II didnot show improved survival following revascularization
compared with optimal medical therapy.31
Increased pulmonary vascular resistance (PVR) estimated by CMR
in systolic heart failure (n ¼ 105, LVEF, 40%, prior heart failure ad-
mission) irrespective of aetiology and the presence of LGE predicted
heart failure readmissions and all-cause mortality.32
Many post-infarct patients with an indication for an implantable
cardioverter defibrillator will not develop ventricular tachycardia.
Measuring intramural scar surface and sub-epicardial scar surface
by CMR appear promising tools to stratify the risk of post-infarct
ventricular tachycardia.33
Congenital heart disease
The Congenital Heart Disease (CHD) programme saw several major
themes emerge in the abstract sessions. Multimodality imaging that
finds a natural home in CHD was represented across several key
themes predominantly Tetralogy of Fallot (TOF).
Timoteo et al.34 presented data from a study aiming to identify
whether RV and/or RA strains derived from 2D-STE are associated
with arrhythmic events in patients with repaired TOF. Conventional
parameters assessing RV function did not materially differ between
patients with and without significant arrhythmia apart from the TA
A′-wave velocity. However, when using 2DSTE, there was a signifi-
cant difference in both the RV and RA strains parameters between
arrhythmic and non-arrhythmic patients. Despite some study limita-
tions, they concluded that compared with conventional echocardio-
graphic parameters, 2DSTE strain measurements (particularly RV)
are associated with arrhythmic events and that RV 2D strain may
be useful for risk stratification of repaired TOF.
Staying with the RV, West et al.35 evaluated the role of echocardi-
ography vs. angiography in the developing field of Melody percutan-
eous pulmonary valve (MPPV) implantation. In 45 adult patients with
CHD, they estimated the maximal instantaneous and mean Doppler
gradient (DPmax andDPmean) and degree of regurgitation as deter-
mined by conventional colour Doppler parameters. These data were
compared with invasive post-implantation peak-to-peak gradient
(DPp-p) which had been recorded during the implantation procedure.
The narrowest dimensions of the MPPV system were taken retro-
spectively from the final biplane orthogonal fluoroscopic images to
calculate the effective valve orifice area (EOA). There was poor
agreement between the invasive DPp-p (11.5+5.2 mmHg) and the
DPmax and DPmean (33.3+8.2 mmHg and 19.3+ 6.5 mmHg,
respectively) with Doppler echocardiography being greater than
the invasive pressures. There were only weak relationships between
the indexed EOA and the invasive and Doppler gradients. They con-
clude that Doppler gradient for the percutaneous Melody valve
system early after implantation is consistently higher than the invasive
DPp-p gradient, but still provides a valuable baseline assessment for
future serial assessment. These results reflect the complex and vari-
able anatomy of the RV outflow tract/main pulmonary artery in this
group of patients, all of whom had previously undergone surgery.
Moving on to new techniques, Kutty et al.36 presented preliminary
work on rotation intensity and energy dissipation of RV flow in TOF
compared with normal controls using echo contrast Particle Imaging
Velocimetry (PIV), which combines 2DSTE and contrast enhanced
echocardiography to determine the velocity and direction of fluid
streams by analysing the change in position of particles (Figure 5). Al-
though previously described in LV, this study look more specifically at
Figure 5 Echocardiographic particle imaging velocimetry derived
RV flow field inanormal control (left panel) and in apatient withTOF
(right panel). Each panel shows one image of the velocity vector field
at one instant (upper), one colour map image of the rotation level at
another instant with superimposed velocities (middle), and the
colour map image of the rotation level for the steady-streaming
(heartbeat averaged) flow field (lower panel). Red indicates counter-
clockwise rotation, and blue indicates clockwise rotation.
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the RV in 16 patients (13–42 years, median 22 years) with repaired
TOF compared with 25 normal controls (23–43 years, median 34
years). Kinetic energy dissipation measure of amount of energy loss
by friction, where the lower the energy dissipation in blood flow
through the ventricular chamber, the higher the ventricular efficiency
and flow rotation intensity was defined as the amount of swirl calcu-
lated ‘inside the vortex’ normalized with the total swirl in the whole
chamber. The study was limited by the complex geometry of the RV,
the two-dimensional nature of the technique and the difficulty in cap-
turing progression of flow into the RV outflow tract in the four-
chamber plane, the patients were not age matched and the number
of patients was small. Despite these limitations, the investigators con-
cluded that measurement of intraventricular flow parameters by PIV
is feasible in both ventricles for normal individuals and most patients
after surgical repair of TOF and that in this group of patients with
repaired TOF and relatively favourable haemodynamic outcomes
with preserved systolic function, RV, and LV flow parameters were
different from those of normal controls.
The3DE is nowstandardof care for CHD.Karsentyet al.37 presented
data from their study using 3D-TTE to assess ventricular septal defect
(VSD) anatomy and severity. There were significant differences in the
maximum and minimum VSD diameters when measured on 3DE com-
paredwith2D-TTE.Thestudyconclusionswerethat2Dunderestimates
the VSD size compared with 3D and that 3D-TTE was useful to estimate
VSD severity in some situations when the Doppler unhelpful.
Finally, Cantinotti et al.38 presented initial data from a very large
single-centre studyof 1091children (0–17years)where23 individual
cardiac structures were measured echocardiographically to develop
standardizednomograms forchamber dimensions andareas in paedi-
atric echocardiography. This work represents the largest normal
values report for healthy infants and children and will allow more
accurate calculation of z score across the paediatric population.
Nuclear cardiology and cardiac
computed tomography
Coronary CT angiography (CCTA) is an emerging imaging approach
for the diagnosis of coronary artery disease (CAD). It is recommended
bycurrentESCguidelines, asanalternative toother imagingmodalities,
in patients with stable chest pain and low-to-intermediate pre-test
disease probability (PTP).
Figure 6 PET/CT imaging in ApoE2/2 and C57Bl/6 mice. Representative PET/CT images of ApoE2/2 and C57Bl/6 mice 2–3 h after injection of
the radiotracer. Focal uptake of 18F-cAbVCAM1-5 nanobody is visible at the level of aortic arch of ApoE2/2 mice while background uptake is
observed in C57Bl/6 control mice and in ApoE2/2 mice injected with control nanobody. This focal uptake is specific as it could be blocked by
an excess of unlabelled nanobody. Arrow indicates aortic arch.
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Demir et al.39 retrospectively reviewed 157 consecutive patients
with suspected CAD who were submitted to CCTA between 2012
and 2014. Theyshowed that the predictive models of PTPand cardio-
vascular risk, proposed by ESC (2013) and UK NICE (2010) guide-
lines, have a poor agreement and more importantly overestimate
the prevalence of CAD at CCTA. Hence, more effective models
are needed to better guide the appropriate use of imaging.
The high negative predictive value of CCTA could allow an
effective filtering to invasive angiography in patients with low risk.
Aguiar Rosa et al.40 demonstrated that the introduction of CCTA
as an additional screening test in their institution significantly
increased the rate of CAD diagnosed invasively from 43 to 90%
and the rate of angioplasties from 29 to 60%. Large randomized con-
trolled trials are needed to comparatively assess the impact of
imaging modalities on the diagnostic and therapeutic yield of invasive
procedures.
To assess the comparative cost-effectiveness of CCTA and cardiac
stress imaging (CSI) modalities, alone or in combination, to diagnose
CAD, Petersen et al.41 developed a simulation model based on pub-
lished literature and on the perspective of three countries: the USA,
the UK, and The Netherlands (NL). Their target population was
based on 60-year-old patients with 30% PTP of CAD. Despite the dif-
ferences in outcome (QALYs) were small across strategies, CCTA as
triage test prior to CSI was cost-effective (in the USA and NL) with
CCTA + ECHO being most cost-effectiveness. Though difficult to
be performed, prospective comparative cost-effectiveness studies
are warranted.
Perfusion imaging by single-photon emission computed tomog-
raphy (SPECT) or positron emission tomography (PET) is a robust
stress imaging modality in patients with suspected or known CAD
due to its well-demonstrated prognostic value. Al Mallah et al.42
showed that it holds true also in patients with LBBB that may cause
septum perfusion defects of uncertain interpretation. In a series of
706 patients with LBBB undergoing vasodilator stress SPECT, resting
and stress perfusion defects added incremental prognostic infor-
mation for all-cause mortality and non-fatal myocardial infarction in
a median follow-up period of 35 months.
An original application of nuclear imaging is the visualization of the
calcification process in heart valves. Dweck et al.43 measured active
valvular calcification using PET/CT and 18F-sodium fluoride tracer
(18F-NaF) in 121 volunteers with and without AS. The authors ob-
served a significant correlation between baseline valvular 18F-NaF
uptake and the progression in calcium score or echocardiographic
haemodynamic measurements in a 2 years follow-up. Valvular 18F-NaF
was an independent predictor of aortic valve replacement and
cardiovascular death.
An exciting new application of nuclear modalities is imaging of
inflammatory processes. The recognition of the vulnerable plaque
is the holy grail of vascular imaging research. Vascular cell adhesion
molecule-1 (VCAM-1) is expressed in inflammatory atherosclerotic
lesions and is a potential target for molecular imaging of vulnerable
plaques. Bala et al.44 demonstrated that mouse/human cross-reactive
anti-VCAM-1 nanobodies (Nb), radiolabelled with 18F, specifically
bind with VCAM-1-positive isolated cells (Figure 6). They also
showed that atherosclerotic lesions in the aortic arch of ApoE2/2
mice injected with 18F-anti-VCAM-1 Nb could be successfully identi-
fied using mPET/CT imaging. Whether successfully transferred to
humans, this approach may represent an attractive tool for imaging
vulnerable atherosclerotic plaques in patients.
Imaging the inflammatory process elicited in the myocardium after
acute ischaemic injury is another prospectively important goal.
Tierens et al.45 used pinhole-SPECT/CT and 99mTc-labelled nano-
bodies targeting the macrophage mannose receptor (MMR Nb)
to image M2-mediated inflammation in a myocardial ischaemia/
reperfusion rat model. They demonstrated significant retention of
99mTc-Nbs in the infarcted myocardium where immunofluorescent
staining confirmed the presence of MMR. These results may open
new opportunities to follow the impact of various treatment strat-
egies on inflammation modulation in acute ischaemic heart disease.
Conflict of interest: none declared.
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